Cointime

Astrocyte Pharmaceuticals

company

About

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.

  • 1 - 10

Highlights

Total Funding Amount
$6M
Funding Rounds
2
Investors
3
Investments
1

Details

Last Funding Type
Grant
Industries
Biotechnology,Clinical Trials,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2014
Number Of Employee
1 - 10
Operating Status
Active

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke, TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$6M
Astrocyte Pharmaceuticals has raised a total of $6M in funding over 2 rounds. Their latest funding was raised on May 3, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 3, 2021 Series A $6M 2 — — Detail
Sep 21, 2015 Grant — 1 National Institutes of Health — Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Astrocyte Pharmaceuticals has made 1 investments. Their most recent investment was on Nov 6, 2019, when Digits raised $10.50M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 6, 2019 Digits
Series A $10.50M Artificial Intelligence —

Investors

Number of Lead Investors
Number of Investors
1
3
Astrocyte Pharmaceuticals is funded by 3 investors. National Institutes of Health and DREAMERS Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
DREAMERS Ventures — Series A
Zhi Gao Holding — Series A
Cointime
เนื้อหา
บริษัท